Sevelopment of new veterinary medicines

About Avimedical

Avimedical is a young company with the ambition to provide well-researched veterinary drugs of excellent quality.

In the context of quality assurance, the company collaborates with several research institutions that have extensive experience in developing and testing veterinary drugs. In addition, Avimedical BV has its own research facilities at its disposal and accommodates close collaboration with several veterinary practices. This ensures both good practical applicability and maximum effectiveness.

One of Avimedical BV’s goals is to increase the availability of safe and effective drugs specifically for birds and exotic pets. The number of registered veterinary drugs for this special group of pets is very limited. For this reason, new registered resources are very welcome.

During the registration processes, studies are conducted with the veterinary drugs in the target animal species. These extensive studies prior to marketing these drugs serve to minimise the likelihood of unwanted and unexpected side effects and maximise clinical effectiveness.

In many cases, the pharmacokinetics of this particular group of pets has not been studied as extensively as (for example) in dogs and cats. For this reason, the extensive research prior to general use is a valuable advantage over veterinary drugs that are registered for other animals and adopted without research. This can serve to prevent resistance, ensuring a good effect with as few side effects as possible.